BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Biotech Bay

  Threshold Pharmaceuticals, Inc. Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 American Society of Clinical Oncology Annual Meeting

  June 3, 2013

   · 

  7 min read
• BioForest

  Galena Biopharma Provides Product Pipeline Update at the American Society of Clinical Oncology 2013 Annual Meeting

  June 3, 2013

   · 

  1 min read
• Lone Star Bio

  Curis, Inc. American Society of Clinical Oncology Presentation Highlights the Utility of Molecular Profiling for the Management of Rare and Aggressive Cancers

  June 3, 2013

   · 

  4 min read
• Drug Development

  BioMarin Pharmaceutical Inc. Provides Preliminary Data on Ongoing Phase 1/2 Trial for BMN 673 for the Treatment of Solid Tumors at 2013 American Society of Clinical Oncology Annual Meeting

  June 3, 2013

   · 

  1 min read
• Drug Development

  TopoTarget A/S Release: Positive Data From the BELIEF trial presented at the 2013 American Society of Clinical Oncology Annual Meeting

  June 3, 2013

   · 

  1 min read
• Drug Development

  Karyopharm Therapeutics Presents Clinical Data for Selinexor (KPT-330), a First-in-Class Selective Inhibitor of Nuclear Export (SINE), in Solid Tumors at the 2013 American Society of Clinical Oncology Annual Meeting

  June 3, 2013

   · 

  1 min read
• Drug Development

  EpiCept Corporation Announces New Crolibulin Data Presented at American Society of Clinical Oncology 2013 Support Further Evaluation in Anaplastic Thyroid Cancer

  June 3, 2013

   · 

  1 min read
• Drug Development

  KAEL–GemVax Release: Final Results From the Phase III TeloVac Trial in Pancreatic Cancer Presented at American Society of Clinical Oncology, Chicago, June 3rd 2013.

  June 3, 2013

   · 

  1 min read
• Genetown

  ArQule, Inc. Release: Phase 2 Study Results for Tivantinib in Combination with Cetuximab and Irinotecan for Colorectal Cancer Presented at American Society of Clinical Oncology 2013

  June 3, 2013

   · 

  1 min read
• BioForest

  NanoString Technologies Inc. Announces Oral Study Presentation of the Prosigna™ Assay in Postmenopausal Node-Positive Breast Cancer at the 2013 Annual American Society of Clinical Oncology

  June 3, 2013

   · 

  1 min read